Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,601 | -1,318 | -1,354 | -2,380 | -1,628 |
| Depreciation Amortization | 9 | 4 | 2 | 686 | 60 |
| Other Working Capital | 810 | 499 | 353 | 1,226 | 766 |
| Other Operating Activity | 493 | 566 | 832 | 412 | 548 |
| Operating Cash Flow | $-290 | $-248 | $-167 | $-56 | $-253 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -17 | -15 | 0 | -28 | -16 |
| Other Investing Activity | -17 | -15 | 0 | -28 | -16 |
| Investing Cash Flow | $-17 | $-15 | $0 | $-28 | $-16 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 302 | 261 | 167 | N/A | 215 |
| Common Stock Issued | 13 | 0 | N/A | 63 | 63 |
| Financing Cash Flow | $316 | $261 | $167 | $63 | $278 |
| Beginning Cash Position | 5 | 5 | 5 | 26 | 26 |
| End Cash Position | 15 | 3 | 4 | 5 | 35 |
| Net Cash Flow | $9 | $-2 | $-1 | $-21 | $9 |
| Free Cash Flow | |||||
| Operating Cash Flow | -290 | -248 | -167 | -56 | -253 |
| Free Cash Flow | -290 | -248 | -167 | -56 | -253 |